Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 Category:Investigational Category:Antibody medications") |
m |
||
| Line 2: | Line 2: | ||
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | ||
| − | [[Category: | + | [[Category:Drug index]] |
| + | [[Category:Chemotherapy]] | ||
[[Category:Antibody medications]] | [[Category:Antibody medications]] | ||
| + | |||
| + | [[Category:Investigational]] | ||
Revision as of 04:58, 23 November 2014
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3